| Name | MC-1-F2 |
|---|
| Description | MC-1-F2 is a FOXC2 inhibitor that reduces epithelial-mesenchymal transition (EMT) markers in breast cancer cells, suppresses cancer stem cell (CSC) properties and reduces invasiveness in castration-resistant prostate cancer (CRPC) cells. There is a synergistic effect between MC-1-F2 and Docetaxel, which has the potential to be used in combination to study CRPC[1]. |
|---|---|
| Related Catalog | |
| Target |
FOXC2[1]. |
| References |
| Molecular Formula | C37H46N16O2 |
|---|---|
| Molecular Weight | 746.87 |